Lymphoma Treatment Options

Lymphoma, a heterogeneous hematological malignancy, can be broadly categorized into Hodgkin lymphoma and non-Hodgkin lymphoma. Long-term lymphoma patients require comprehensive analysis based on the lymphoma type, stage, and other factors to select a reasonable treatment plan, encompassing Hodgkin lymphoma, non-Hodgkin lymphoma, as well as T-cell lymphoma and B-cell lymphoma.

Hodgkin Lymphoma

The preferred treatment regimen for Hodgkin lymphoma is a combination of chemotherapy and radiotherapy. Chemotherapy options include drugs such as doxorubicin hydrochloride for injection and bleomycin hydrochloride for injection. Radiotherapy options may involve high-frequency radiation and external beam radiation. Treatment must be completed as prescribed by the doctor, avoiding self-adjustments to the plan.

Non-Hodgkin Lymphoma

Similar to Hodgkin lymphoma, the first-choice treatment for non-Hodgkin lymphoma is also a combination of chemotherapy and radiotherapy. Chemotherapy options can include doxorubicin hydrochloride for injection and bleomycin hydrochloride for injection. Radiotherapy options encompass high-frequency radiation and external beam radiation. Treatment should follow the doctor's instructions, refraining from making changes to the plan without consultation.

T-Cell Lymphoma

For T-cell lymphoma, the primary treatment approach is a combination of chemotherapy and radiotherapy. Chemotherapy options may involve gemcitabine hydrochloride for injection and doxorubicin hydrochloride for injection. Radiotherapy options include high-frequency radiation and external beam radiation. Treatment adheres to the doctor's instructions, and ensuring adequate rest during chemotherapy is crucial.

B-Cell Lymphoma

B-cell lymphoma is also treated primarily with a combination of chemotherapy and radiotherapy. Chemotherapy options can be doxorubicin hydrochloride for injection and bleomycin hydrochloride for injection. Radiotherapy choices encompass high-frequency radiation and external beam radiation. In addition, for patients with severe conditions, hematopoietic stem cell transplantation may be considered under medical guidance. With standardized treatment, most lymphoma patients can achieve clinical remission, although some may experience recurrence or metastasis. Therefore, patients are advised to comply with regular follow-ups, persist with treatment, and maintain a positive mindset.